🏛️ Verified NIH Record • Updated 2026-08-06
Study of EVO756 in Adults With Migraine (NCT07616128)
A Randomized, Double-Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of EVO756 for the Prevention of Migraine in Adults
🟢 Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: Evommune, Inc.
🩺 Plain-English Summary (8th-Grade Level)
This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.
Who can join: Review the eligibility criteria below.
Location: Trialsphere Corp — Chandler, Arizona
Age range: 18 Years to 64 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (20 Sites)
- Trialsphere Corp — Chandler, Arizona
- Neuro Pain Research Center — Fresno, California
- CA Medical Clinic for Headache — Los Angeles, California
- Diablo Clinical Research dba Flourish Research — Walnut Creek, California
- New England Institute for Neurology and Headache — Stamford, Connecticut
- Clinical Neuroscience Solutions, Inc. — Jacksonville, Florida
- Apple Medical Research Group, Inc — Miami, Florida
- Clinical Neuroscience Solutions, Inc. — Orlando, Florida
- Vantage Clinical Trials — Tampa, Florida
- Accel Research Site-Decatur-Alcanza — Decatur, Georgia
- Michigan Headache and Neurological Institute — Ann Arbor, Michigan
- Bio Behavoural health — Toms River, New Jersey
- Clinosis - Dent Neurologic Instite — Amherst, New York
- Asheville Neurology Specialists, Pa — Asheville, North Carolina
- Eximia Research NC — Raleigh, North Carolina
- Clinical Trials of South Carolina — Charleston, South Carolina
- FutureSearch Trials of Neurology — Austin, Texas
- FutureSearch Trials of Dallas — Dallas, Texas
- SFF Medical Research Group LLC — Houston, Texas
- Vaught Neurological Services — Crab Orchard, West Virginia
📞 Contact the Study Coordinator
Phone: (650) 319-4553
Email: nichole.baio@evommune.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Migraine
- A Study of Wearable Devices to Predict Migraines — Rochester, Minnesota
- Treatment for Migraine and Mood — The Bronx, New York
- Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine — Birmingham, Alabama
- A Study to Evaluate White Matter Hyperintensities in Migraine — Phoenix, Arizona
- Migraine Manager (R01) — Cincinnati, Ohio
- Nerivio Efficacy Under High-Frequency Use — Bridgewater, New Jersey
Explore by condition: All Migraine clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.